Announcements Trials
Browse Landscape

Status

Unknown 2Terminated 2Recruiting 2Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Cancer Metastatic to Liver 1Choledocholithiasis 1Cholangitis, Sclerosing 1Cholangiocarcinoma 1Biliary Fistula 1

Interventions

Leucovorin 5Gemcitabine 5Fluorouracil 5Cisplatin 5durvalumab 3Oxaliplatin 3Capecitabine 3pembrolizumab 2lenvatinib 2S 1 (combination) 2Irinotecan 2Folfox protocol 2zimberelimab 1tocilizumab 1tislelizumab 1surufatinib 1regorafenib 1pemigatinib 1neratinib 1fludarabine 1donafenib 1dehydroftorafur 1Surgical Procedures, Operative 1Radiotherapy 1Proton Therapy 1Platinum 1Magnetic Resonance Spectroscopy 1Immunoglobulin G 1Immune Checkpoint Inhibitors 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Cholangiocarcinoma × Cholangiopancreatography, Endoscopic Retrograde × Clear all
NCT06670547 2024-11-01

Spanish Registry of Quality Indicators and Adverse Events of Endoscopic Retrograde Cholangiopancreatography

Germans Trias i Pujol Hospital

Not yet recruiting
3,000 enrolled
Gastrointestinal

Biliary Fistula, Cholangitis, Sclerosing, Cholangiocarcinoma, Choledocholithiasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡